Focus Partners Wealth Increases Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Focus Partners Wealth increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 127.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,917 shares of the biotechnology company’s stock after buying an additional 1,073 shares during the period. Focus Partners […]
Focus Partners Wealth increased its position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 127.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,917 shares of the biotechnology company’s stock after buying an additional 1,073 shares during the period. Focus Partners […]
